Collectively, these studies suggest that administration of compounds targeting SLC7A11 to promote RT-induced ferroptosis is likely a promising strategy for radiosensitization in vivo, which is in line with other studies targeting SLC7A11 for tumor suppression (Badgley et al., 2020; Hu et al., 2020). This evidence concerns the gene SLC7A11 and neoplasm.